Pain-blocking gene mutation may hold clues for drug developers

Pharmaceutical researchers are studying a mutation in the SCN9A gene that makes patients immune to pain. While medications can mute pain, new experimental formulations that try to mimic the gene mutation aim to stop nerve cells from sending pain signals to the brain.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC